![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
44 分鐘
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Bringing A Hub-and-Spoke Business Model to Regenerative Medicine Bioverge
-
- 商業
Faizzan Ahmad, Co-Founder and CEO of Cure8bio, sits down with Neil to discuss its growing portfolio of regenerative medicines in development, its hub-and-spoke business model designed to leverage resources and reduce risk, and its push toward curative therapies.
Faizzan Ahmad, Co-Founder and CEO of Cure8bio, sits down with Neil to discuss its growing portfolio of regenerative medicines in development, its hub-and-spoke business model designed to leverage resources and reduce risk, and its push toward curative therapies.
44 分鐘